Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. Moderna, Inc.
  6. News
  7. Summary
    MRNA   US60770K1079

MODERNA, INC.

(MRNA)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

With new Omicron case detected, UK awaits COVID booster advice

11/28/2021 | 04:34am EST

* UK wants to broaden booster campaign

* New measures are temporary

* Scotland also to introduce travel measures

LONDON, Nov 28 (Reuters) - Britain's health minister Sajid Javid said on Sunday he expected to receive advice imminently on whether the government can broaden a booster shot programme to try to weaken the impact of the newly identified Omicron coronavirus variant.

A day after Britain said it had detected two cases of the variant, its health agency recorded a third - in a person who was linked to travel to Southern Africa but had since left the country after spending time in the capital London.

The government announced new measures on Saturday to try to slow the spread of the variant, toughening rules for people arriving into Britain and ordering the use of masks in retail settings and on transport in England. Some schoolchildren will also be required to wear face coverings in communal areas.

But ministers also want to ramp up the offer of booster jabs, saying even if vaccines prove to be less effective against Omicron, they should offer better protection against it and reduce the number of hospitalisations and deaths.

"The other thing that still remains hugely important, but I think it's fair to say now more important than it was before, is our vaccination programme," Javid told Sky News.

"That is why I have also asked our expert advisers on vaccines called JCVI (the Joint Committee on Vaccination and Immunisation) to give me very quick advice on broadening, boosting our booster programme, and I expect to get that advice imminently."

Earlier this month, Britain expanded eligibility for booster jabs to people in their 40s and also said children aged 16 and 17 would be able to receive a second dose following guidance from the JCVI.

Scotland, where the government sets its own health rules, already requires people to wear face coverings and work from home if possible. First Minister Nicola Sturgeon told the BBC's Andrew Marr show she would also bring in new rules for arrivals.

"I think we need to be open minded to doing anything required to keep the population safe right now," she said.

BUYING TIME

The discovery of Omicron, dubbed a "variant of concern" last week by the World Health Organization, has caused worry around the world https://www.reuters.com/world/new-coronavirus-variant-omicron-keeps-spreading-australia-detects-cases-2021-11-28 that it could resist vaccinations and prolong the nearly two-year COVID-19 pandemic.

Almost 145,000 people have died from COVID-19 in Britain, with Johnson's government criticised for moving too slowly in the early days of the pandemic. Since then, the government has tried to react quickly to the appearance of new variants.

Javid said the new measures were needed to buy time for experts to understand more about Omicron, which is likely to have spread in Britain beyond the three cases so far detected.

Jenny Harries, chief executive of the UK's Health Security Agency, said: "It is very likely that we will find more cases over the coming days."

Paul Burton, chief medical officer at Moderna, said that if a new vaccine was needed, "I think that's going to be early 2022 before that’s really going to be available in large quantities".

Javid said it was not as yet clear whether vaccines were less effective against the variant.

"The point is the vaccines are still going to give you more protection than otherwise," he said. "That is why the booster programme is so important." (Reporting by Elizabeth Piper, Editing by Louise Heavens, Mark Heinrich, Raissa Kasolowsky and Catherine Evans)


ę Reuters 2021
Stocks mentioned in the article
ChangeLast1st jan.
ASTRAZENECA PLC -0.48% 8728 Delayed Quote.0.56%
MODERNA, INC. -8.85% 186.61 Delayed Quote.-26.53%
All news about MODERNA, INC.
01/18US Stocks Slump as Treasury Yields Hit 2-Year High, Goldman Sachs Weighs on Financials
MT
01/18US Stocks Start Week Lower as Treasury Yields Hit 2-Year High, Goldman Sachs Weighs on ..
MT
01/18Morgan Stanley Adjusts Moderna Price Target to $315 From $313, Maintains Equal Weight R..
MT
01/18Equities Slump Midday After Treasury Yields Touch Two-Year High, Goldman's Earnings Mis..
MT
01/18MIDDAY REPORT : US Stocks Slump After Treasury Yields Touch Two-Year High; Goldman's Earni..
MT
01/18EU regulator finds mRNA COVID-19 shots safe during pregnancy
RE
01/18European Medicines Agency Says mRNA COVID-19 Vaccines Safe In Pregnancy
MT
01/18EU regulator says mRNA COVID-19 shots do not complicate pregnancies
RE
01/18MARKETSCREENER’S WORLD PRESS REVIEW : January 18, 2022
01/17China's Xi rejects 'Cold War mentality,' pushes cooperation
AQ
More news
Analyst Recommendations on MODERNA, INC.
More recommendations
Financials (USD)
Sales 2021 17 520 M - -
Net income 2021 11 079 M - -
Net cash 2021 9 774 M - -
P/E ratio 2021 7,07x
Yield 2021 -
Capitalization 75 661 M 75 661 M -
EV / Sales 2021 3,76x
EV / Sales 2022 2,60x
Nbr of Employees 1 300
Free-Float 90,5%
Chart MODERNA, INC.
Duration : Period :
Moderna, Inc. Technical Analysis Chart | MRNA | US60770K1079 | MarketScreener
Technical analysis trends MODERNA, INC.
Short TermMid-TermLong Term
TrendsBearishBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 19
Last Close Price 186,61 $
Average target price 273,19 $
Spread / Average Target 46,4%
EPS Revisions
Managers and Directors
StÚphane Bancel Chief Executive Officer & Director
Stephen Hoge President
David W. Meline Chief Financial Officer
Noubar B. Afeyan Chairman
Juan Andres Chief Technical Operations & Quality Officer
Sector and Competitors
1st jan.Capi. (M$)
MODERNA, INC.-26.53%83 008
LONZA GROUP AG-15.15%53 950
IQVIA HOLDINGS INC.-12.33%47 252
SEAGEN INC.-11.33%25 068
ICON PUBLIC LIMITED COMPANY-13.98%21 684
CELLTRION, INC.-19.44%18 710